Drug intelligence / Profile preview

N1-(2-amino-4-methylpentyl)octahydro-pyrrolo[1,2-a]pyrimidine

Development stage
Unknown
Modality
Small Molecules
01

Overview

N1-(2-amino-4-methylpentyl)octahydro-pyrrolo[1,2-a]pyrimidine is a synthetic small molecule with the molecular formula C13H27N3 and a molecular weight of approximately 225.37 g/mol. It belongs to the class of organoheterocyclic compounds known as diazinanes and features a pyrrolopyrimidine core structure. The compound is considered experimental and has not been approved for any therapeutic use or entered clinical trials beyond preclinical investigation. Its mechanism of action and pharmacological targets are not described in publicly available sources; no information on its biological activity or intended indication is currently available.[1][3][9]

Other names
(2S)-1-[(8aR)-octahydropyrrolo[1,2-a]pyrimidin-1-yl]-4-methylpentan-2-aminePyrrolo[1,2-a]pyrimidine-1(2H)-ethanamine, hexahydro-alpha-(2-methylpropyl)-, (alphaS,8aR)-(2S)-1-[(8aR)-hexahydro-2H-pyrrolo[1,2-a]pyrimidin-1-yl]-4-methylpentan-2-amineN1-(2-amino-4-methylpentyl)octahydro-pyrrolo[1,2-a] pyrimidine

Beyond the preview

Go deeper on N1-(2-amino-4-methylpentyl)octahydro-pyrrolo[1,2-a]pyrimidine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N1-(2-amino-4-methylpentyl)octahydro-pyrrolo[1,2-a]pyrimidine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call